Latest filing published 03 Jan 2022 for agilon health, inc., €11k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Theodore Halkias: trading record in brief
All filings by Theodore Halkias on record concern Agilon Health, Inc., in the capacity of senior executive. Between 14 April 2021 and 31 December 2021, the trades on record add up to 12 filings.
Sales make up the whole of the open-market record (6 sales, €4.9M). The rest of the record consists of 1 share grant and 5 option exercises. In 2022 alone, the filings show no purchases and 2 sales.
The latest filing, published on 3 January 2022, reports an open-market sale of €294k in Agilon Health, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Theodore Halkias
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,113 shares@ US$1.0013.5% of flowCommon StockSEC:0001209191-22-000122:0
- 21,142 shares@ US$1.0023.6% of flowCommon StockSEC:0001209191-21-071405:0
- 58,553 shares@ US$1.0062.8% of flowCommon StockSEC:0001209191-21-056202:0
3 of 3 declarations
